BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea
· Delayed Price · Currency is KRW 4,470.00
-25.00 (-0.56%)
Jun 27, 2025, 3:30 PM KST
BCWORLD PHARM. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -4,937 | -4,433 | 2,634 | 281.3 | -1,843 | -1,580 | Upgrade
|
| Depreciation & Amortization | 7,743 | 7,694 | 7,470 | 7,208 | 5,174 | 4,569 | Upgrade
|
| Loss (Gain) From Sale of Assets | 12.43 | -20.77 | -48.91 | 0.32 | 0 | -197.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 64.29 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 27.41 | 28.94 | -13.42 | 535.17 | 229.14 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 371.2 | 55.52 | 223.05 | 34.91 | 49.77 | 67.29 | Upgrade
|
| Other Operating Activities | 2,363 | 2,068 | 642.45 | -1,251 | -2,522 | -3,361 | Upgrade
|
| Change in Accounts Receivable | -1,713 | -2,619 | -1,652 | -1,520 | -1,236 | 1,477 | Upgrade
|
| Change in Inventory | 1,798 | 2,000 | -299.31 | -618.65 | -813.45 | -1,166 | Upgrade
|
| Change in Accounts Payable | 928.3 | 172.23 | -97.11 | 1,381 | -1,420 | -2,002 | Upgrade
|
| Change in Other Net Operating Assets | -375.45 | -903.84 | 2,080 | 767.78 | 1,762 | -3,310 | Upgrade
|
| Operating Cash Flow | 6,218 | 4,042 | 10,938 | 6,883 | -619.83 | -5,502 | Upgrade
|
| Operating Cash Flow Growth | -33.32% | -63.04% | 58.91% | - | - | - | Upgrade
|
| Capital Expenditures | -2,063 | -2,398 | -2,577 | -6,217 | -17,444 | -7,785 | Upgrade
|
| Sale of Property, Plant & Equipment | 41.93 | 41.93 | 64.27 | 192.36 | 106.58 | 157.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -13.51 | -9.95 | -132.03 | -47.31 | -1,201 | 188.81 | Upgrade
|
| Investment in Securities | 1,287 | 1,266 | -553.23 | -862.35 | -5.74 | -665.37 | Upgrade
|
| Other Investing Activities | -22.41 | -38.65 | 81.06 | 431 | 1,020 | 105.05 | Upgrade
|
| Investing Cash Flow | -769.52 | -1,139 | -3,764 | -6,678 | -17,690 | -8,112 | Upgrade
|
| Long-Term Debt Issued | - | 30,693 | 35,830 | 35,680 | 30,700 | 53,687 | Upgrade
|
| Long-Term Debt Repaid | - | -34,674 | -39,535 | -32,951 | -19,509 | -35,970 | Upgrade
|
| Net Debt Issued (Repaid) | -4,413 | -3,980 | -3,705 | 2,729 | 11,191 | 17,717 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -806.57 | - | -24.32 | Upgrade
|
| Dividends Paid | -542.73 | -542.73 | -542.73 | -853.86 | -853.86 | -771.83 | Upgrade
|
| Other Financing Activities | - | - | -0 | 3.7 | -0 | 6,000 | Upgrade
|
| Financing Cash Flow | -4,955 | -4,523 | -4,248 | 1,073 | 10,337 | 22,921 | Upgrade
|
| Foreign Exchange Rate Adjustments | 47.05 | 68.01 | 38.01 | -1.7 | 48.29 | -311.28 | Upgrade
|
| Net Cash Flow | 539.96 | -1,551 | 2,963 | 1,276 | -7,925 | 8,995 | Upgrade
|
| Free Cash Flow | 4,155 | 1,644 | 8,361 | 666.21 | -18,064 | -13,288 | Upgrade
|
| Free Cash Flow Growth | -35.68% | -80.33% | 1154.97% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.59% | 2.20% | 11.13% | 0.92% | -29.10% | -23.30% | Upgrade
|
| Free Cash Flow Per Share | 447.17 | 177.15 | 900.71 | 71.07 | -1923.27 | -1419.62 | Upgrade
|
| Cash Interest Paid | 3,957 | 4,102 | 4,474 | 2,811 | 1,851 | 1,925 | Upgrade
|
| Cash Income Tax Paid | 138.63 | 117.07 | -1,291 | -85.77 | 1,100 | 231.5 | Upgrade
|
| Levered Free Cash Flow | 5,145 | 2,470 | 5,224 | -2,496 | -63,484 | 31,885 | Upgrade
|
| Unlevered Free Cash Flow | 8,032 | 5,445 | 8,495 | -125.88 | -62,129 | 33,397 | Upgrade
|
| Change in Net Working Capital | -1,560 | 778.79 | 243.81 | 2,234 | 47,699 | -37,734 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.